Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The right atrium is one of the four chambers of the heart, serving as the upper right chamber. It receives deoxygenated blood from the systemic circulation (via superior and inferior vena cavae) and the coronary sinus, directing it through the tricuspid valve into the right ventricle for subsequent pumping to the lungs. Beyond its role as a blood reservoir and conduit, it is crucial for cardiac electrical conduction, housing the sinus node (the heart's primary pacemaker) and transmitting electrical signals to the atrioventricular node. Key anatomical features include the Eustachian and Thebesian valves. As an anatomical structure, the right atrium itself is not a molecular or receptor drug target; however, its vital physiological function means it is implicated in various cardiac diseases like atrial fibrillation and amyloidosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Right atrium.